1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Single Photon Emission Computed Tomography Computed Tomography: new trials by email Literature Review of Single Photon Emission Computed Tomography Computed Tomography trials Research Report on Single Photon Emission Computed Tomography Computed Tomography
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer 177Lu-labeled-girentuximab, Nivolumab, 89Zr-girentuximab PET/CT - Clear Cell Renal Cell Carcinoma, Kidney Cancer | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 9 | 2022-02-16 | 2026-01-14 |
Carcinoma, Renal Cell (1) · Kidney Neoplasms (1)
Memorial Sloan Kettering Cancer Center (1)
United States (1)